Clinical Trial Update: Study Assessing Deep Molecular Response in Adult Patients With CML in Chronic Phase Treated With Nilotinib Firstline. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating deep molecular response in adults with chronic-phase Chronic Myeloid Leukemia treated with nilotinib first-line; results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Nilotinib (nilotinib)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Chronic Myeloid Leukemia | Phase 4 | Status: COMPLETED | Results posted: 2022-07-22